Fabino Enterprises Ltd vs Venmax Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Fabino Enterprises Ltd is ₹ 20.31 as of 27 Apr 15:30 . The P/E Ratio of Fabino Enterprises Ltd is 600 as of March 2023 .The P/E Ratio of Venmax Drugs & Pharmaceuticals Ltd is 0 as of March 2023 . The Market Cap of Fabino Enterprises Ltd is ₹ 6.3 crore as of March 2023 .The Market Cap of Venmax Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2023 . The revenue of Fabino Enterprises Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 4.04 crore as compare to the Dec '25 revenue of ₹ 1.62 crore. This represent the growth of 149.38% The ebitda of Fabino Enterprises Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Venmax Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0.11 crore as compare to the Dec '25 ebitda of ₹ 0.04 crore. This represent the growth of 175% The net profit of Fabino Enterprises Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Venmax Drugs & Pharmaceuticals Ltd changed from ₹ 0.01 crore to ₹ 0.11 crore over 8 quarters. This represents a CAGR of 231.66% The Dividend Payout of Fabino Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Venmax Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Fabino Enterprises Ltd

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain.
The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana.
Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'.
A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc.
The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

About Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as 'Yenkay Medico Private Limited', on 28 September, 1998.
The Company thereafter changed its name to 'Yenkey Drugs & Pharmaceuticals Private Limited' on 18 January, 1995.
It became a Public Limited Company on February 3, 1995 as 'Yenkey Drugs & Pharmaceuticals Limited'.
Finally, the Company changed its name to 'Venmax Drugs & Pharmaceuticals Limited' on April 13, 2009. For the past six months, Company focused on establishing chain of Medical Stores with a brand name as 'Ananya Pharma' under the Venmax Drugs & Pharma Limited, with the backing support of Formulations plant (Suzichem Labs).
At present, Company is engaged in the business of pharmaceutical products, drug intermediaries & API's etc. The Company is developing the oncology products in R&D.

FAQs for the comparison of Fabino Enterprises Ltd and Venmax Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Fabino Enterprises Ltd or Venmax Drugs & Pharmaceuticals Ltd?

Market cap of Fabino Enterprises Ltd is 4 Cr while Market cap of Venmax Drugs & Pharmaceuticals Ltd is 29 Cr

What are the key factors driving the stock performance of Fabino Enterprises Ltd and Venmax Drugs & Pharmaceuticals Ltd?

The stock performance of Fabino Enterprises Ltd and Venmax Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fabino Enterprises Ltd and Venmax Drugs & Pharmaceuticals Ltd?

As of May 18, 2026, the Fabino Enterprises Ltd stock price is INR ₹20.31. On the other hand, Venmax Drugs & Pharmaceuticals Ltd stock price is INR ₹25.3.

How do dividend payouts of Fabino Enterprises Ltd and Venmax Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Fabino Enterprises Ltd and Venmax Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.